Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Will Roll Out New Product Every Other Quarter; Will Firm Split in Two?

This updated version serves to clarify a misstatement of fact made by a Sequenom official related to the company's cash position. Sequenom currently has $105 million in the bank and will burn roughly $35 million over the next 12 months.

NEW YORK, Oct. 9 - Sequenom will release a new product every six months and push its systems and consumables business into profitability by the end of next year, a company official said today.

 

For starters, Sequenom said that over the next three months it will launch a new SNP-discovery line of products that'll include tools for microbial identification and DNA methylation detection, said Toni Schuh, president and CEO.

 

In the first quarter of 2003 Sequenom will roll out a free-standing Rapid Thermocycler, which originally came bundled with the MassARRAY 20K and 200K systems. A few months after that, customers can expect to see a desktop MassARRAY tool that Schuh said will cost between $250,000 and $280,000 apiece.

 

On the business side, Schuh, who spoke to investors at the UBS Warburg global health-sciences meeting here this afternoon, said the company has around $110 million in cash today and expects to burn $35 million of that over the next 12 months.

 

Though Schuh spent a good part of his time behind the podium highlighting Sequenom's two distinct business units--systems and pharmaceuticals--his pause when asked whether the units will be formally separated was too long for comfort.

 

"The pharmaceutical business and the systems business are entirely different animals. Customers know they are distinct. They will go their own way," Schuh said cryptically. He declined to elaborate.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.